Hubrecht Institute - KNAW and University Medical Center, Utrecht, the Netherlands.
FEBS J. 2010 Mar;277(6):1562-70. doi: 10.1111/j.1742-4658.2010.07584.x. Epub 2010 Feb 11.
Receptor protein-tyrosine phosphatase alpha (RPTPalpha) is a transmembrane protein with tandem cytoplasmic phosphatase domains. Most of the catalytic activity is contained by the membrane-proximal catalytic domain (D1). We found a spontaneous Arg554 to His mutation in the pTyr recognition loop of the membrane-distal phosphatase domain (D2) of a human patient. This mutation was not linked to the disease. Here, we report that the R554H mutation abolished RPTPalpha-D2 catalytic activity. The R554H mutation impaired Src binding to RPTPalpha. RPTPalpha, with a catalytic site cysteine to serine mutation in D2, also displayed diminished binding to Src. Concomitant with decreased Src binding of the R554H and C723S mutants compared with wild-type RPTPalpha, enhanced phosphorylation of the inhibitory Src Tyr527 site was observed, as well as reduced Src activation. To confirm that catalytic activity of RPTPalpha-D2 was required for these effects, we analyzed a third mutant, RPTPalpha-R729K, which had an inactive D2. Again, Src binding was reduced and Tyr527 phosphorylation was enhanced. Our results suggest that a catalytically active D2 is required for RPTPalpha to bind and dephosphorylate its well-characterized substrate, Src.
受体蛋白酪氨酸磷酸酶 α(RPTPα)是一种具有串联细胞质磷酸酶结构域的跨膜蛋白。大部分催化活性包含在靠近膜的催化结构域(D1)中。我们在人类患者的膜远侧磷酸酶结构域(D2)的 pTyr 识别环中发现了一个自发的 Arg554 到 His 突变。该突变与疾病无关。在这里,我们报告 R554H 突变消除了 RPTPα-D2 的催化活性。R554H 突变损害了Src 与 RPTPα 的结合。具有 D2 催化位点半胱氨酸到丝氨酸突变的 RPTPα 也显示出与 Src 的结合减少。与野生型 RPTPα相比,R554H 和 C723S 突变体与 Src 的结合减少,同时观察到Src Tyr527 抑制性位点的磷酸化增强,以及 Src 激活减少。为了证实 RPTPα-D2 的催化活性对于这些效应是必需的,我们分析了第三个突变体,RPTPα-R729K,它具有无活性的 D2。同样,Src 结合减少,Tyr527 磷酸化增强。我们的结果表明,对于 RPTPα 结合并去磷酸化其特征性底物 Src,需要一个具有催化活性的 D2。